Valencia

• Feasibility study of Neo-adjuvant (before surgery) versus Adjuvant (after surgery) chemotherapy in Upper Tract Urothelial Carcinoma Under evaluation
  2024-514991-41-01 4 Upper Tract Urothelial Carcinoma. Upper urinary tract transitional cel
• ABTECT-1 – ABX464 Treatment Evaluation for ulcerative Colitis Therapy -1 Not authorised
  2022-500535-36-00 5 Moderately to severely active ulcerative colitis
• ABTECT-Maintenance – ABX464 Treatment Evaluation for ulcerative Colitis Therapy Not authorised
  2022-500537-84-00 5 Moderately to severely active ulcerative colitis
• Phase2, double-blind, randomized, placebo-controlled, multicentre study to evaluation the safety, efficacy, and pharmacokinetics of TAK-242 … Not authorised
  2022-501026-37-00 4 ACLF is a syndrome that occurs in patients with chronic liver disease,
• Clinical trial of MK-7648A in adults and children with skin cancer Not authorised
  2022-501417-31-00 5 High-risk Resected Melanoma
• A Study to Assess if BIIB080 Can Change Clinical Dementia Rating-Sum of Boxes Scores, and BIIB080 Safety and Tolerability When Injected Into … Not authorised
  2022-501644-15-00 4 Mild Cognitive Impairment due to Alzheimer's Disease Alzheimer's Disea
• MK-0616-013 Not authorised
  2022-502777-42-00 5 Hypercholesterolemia
• Evaluation of the efficacy and safety of eneboparatide (AZP-3601) in patients with chronic hypoparathyroidism (CALYPSO) Not authorised
  2022-503126-12-00 5 Hypoparathyroidism
• A Phase I Study of RO7589831 in Participants with Advanced Solid Tumors Not authorised
  2023-503170-20-00 1 Advanced solid tumors
• Study BT8009-230 in Subjects with Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2) Not authorised
  2023-504231-41-00 10 Locally advanced or metastatic urothelial cancer
• A phase I/II trial of ABTL0812 in children with relapsed/refractory neuroblastoma and other solid tumours Not authorised
  2023-504246-64-00 9 Relapsed/refractory neuroblastoma and other solid tumours
• HARMONi-3 Not authorised
  2023-504989-37-00 5 Metastatic Squamous Non-small Cell Lung Cancer
• Phase 3, Two-stage, Randomized Study of ONC-392 Versus Docetaxel in Metastatic Non-Small Cell Lung Cancers that Progressed on PD-1/PD-L1 Inh … Not authorised
  2023-505311-20-00 5 Metastatic Non-Small Cell Lung Cancer
• Clinical validation study of urinary clusterin and EGF in patients with chronic kidney disease Not authorised
  2023-507449-27-00 6 Chronic kidney disease
• Evaluation of the safety and efficacy of the drug AL8326 in the post-first treatment of small cell lung cancer. Not authorised
  2023-509067-24-00 4 Small Cell Lung Cancer (SCLC) patients who need ≥2nd line treatment wi
• Phase 2 Open Label Prospective Dose-Ranging Clinical Trial with Escalation and Expansion Cohorts to Evaluate Safety, Tolerability, Pharmacok … Not authorised
  2024-510582-42-00 4 Acute graft versus host disease (aGvHD)
• A phase 2 study to research the safety and efficacy of datopotamab deruxtecan for non-squamous non-small cell lung cancer patients with acti … Not authorised
  2024-512369-14-00 4 Non-small cell lung cancer (NSCLC).
• Effect of Copper CU64 PSMA I&T scanning to detect potential disease spread to lymph nodes in men with newly diagnosed Prostate Cancer Not authorised
  2024-512754-16-00 5 Prostate cancer
• Clinical trial of selinexor plus gemcitabine in selected advanced soft-tissue sarcomas Not authorised
  2024-514827-40-00 9 Patients with advanced soft-tissue sarcoma (leiomyosarcoma or malignan
• A study to find how well budoprutug (TNT119) works and how safe it is in participants with immune thrombocytopenia Not authorised
  2024-519745-30-00 9 Immune Thrombocytopenia (ITP)
• A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc … Unknown
  2022-502779-40-99 5 Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
• A clinical study of MK-7240 for the treatment of ulcerative colitis (MK-7240-001) Unknown
  2025-523766-25-00 5 Ulcerative colitis
• MENOPUR and REKOVELLE in Women UnderGoing an assisted reproductive technology cycle Pending
  2022-500308-23-00 11 Infertility in women undergoing assisted reproductive technologies (AR
• Elranatamab Post Trial Access Study for Participants With Multiple Myeloma Pending
  2023-505200-33-00 5 Multiple myeloma

Showing 1–24 of 1,853 trials